Cargando…
Sustained Virologic Response and Costs Associated with Direct-Acting Antivirals for Chronic Hepatitis C Infection in Oklahoma Medicaid
BACKGROUND: Outcomes involving newer direct-acting antiviral (DAA) hepatitis C virus (HCV) regimens have not been studied extensively among the Medicaid population. OBJECTIVE: To assess clinical (treatment failure) and economic outcomes for chronic HCV-infected Oklahoma Medicaid members following tr...
Autores principales: | Pham, Timothy T., Keast, Shellie L., Farmer, Kevin C., Thompson, David M., Rathbun, R. Chris, Nesser, Nancy J., Holderread, Bethany P., Skrepnek, Grant H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398076/ https://www.ncbi.nlm.nih.gov/pubmed/29952711 http://dx.doi.org/10.18553/jmcp.2018.24.7.664 |
Ejemplares similares
-
State Medicaid Programs Bring Managed Care Tenets to Fee for Service
por: Keast, Shellie L., et al.
Publicado: (2016) -
Evaluation of Abuse-Deterrent or Tamper-Resistant Opioid Formulations on Overall Health Care Expenditures in a State Medicaid Program
por: L. Keast, Shellie, et al.
Publicado: (2016) -
Impact of a Prior Authorization Policy for Montelukast on Clinical Outcomes for Asthma and Allergic Rhinitis Among Children and Adolescents in a State Medicaid Program
por: Keast, Shellie L., et al.
Publicado: (2014) -
Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
por: Noureddin, Mazen, et al.
Publicado: (2018) -
Mixed cryoglobulinaemia vasculitis after sustained hepatitis C virological response with direct-acting antivirals
por: Barbieri, Diego, et al.
Publicado: (2018)